GERN

Geron Corporation (GERN)

About Geron Corporation (GERN)

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.

Details

Daily high

$4.30

Daily low

$4.12

Price at open

$4.29

52 Week High

$5.34

52 Week Low

$1.64

Market cap

2.6B

Dividend yield

0.00%

Volume

6.0M

Avg. volume

8.2M

P/E ratio

-12.04

Geron Corporation News